findmyKOL
Clinical trialNCT05061550RecruitingPhase 2Interventional

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

SponsorAstraZenecaEnrollment630Non-small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

97 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Research Site

    Ghent, Belgium

    Recruiting
  • Research Site

    Ghent, Belgium

    Completed
  • Research Site

    Roeselare, Belgium

    Recruiting
Canada
  • Research Site

    Edmonton, Alberta, Canada

    Completed
  • Research Site

    Winnipeg, Manitoba, Canada

    Recruiting
  • Research Site

    Montreal, Quebec, Canada

    Recruiting
  • Research Site

    Montreal, Quebec, Canada

    Recruiting
France
  • Research Site

    Avignon, France

    Recruiting
  • Research Site

    Bobigny, France

    Withdrawn
  • Research Site

    Bordeaux, France

    Recruiting
  • Research Site

    Limoges, France

    Recruiting
  • Research Site

    Rennes, France

    Recruiting
  • Research Site

    Rouen, France

    Recruiting
  • Research Site

    Suresnes, France

    Recruiting
  • Research Site

    Toulon, France

    Recruiting
Hungary
  • Research Site

    Kecskemét, Hungary

    Recruiting
  • Research Site

    Székesfehérvár, Hungary

    Recruiting
  • Research Site

    Tatabánya, Hungary

    Completed
  • Research Site

    Törökbálint, Hungary

    Recruiting
Ireland
  • Research Site

    Dublin, Ireland

    Recruiting
  • Research Site

    Dublin, Ireland

    Recruiting
  • Research Site

    Dublin, Ireland

    Recruiting
  • Research Site

    Galway, Ireland

    Recruiting
Italy
  • Research Site

    Aviano, Italy

    Recruiting
  • Research Site

    Brescia, Italy

    Recruiting
  • Research Site

    Catanzaro, Italy

    Withdrawn
  • Research Site

    Florence, Italy

    Recruiting
  • Research Site

    Genova, Italy

    Recruiting
  • Research Site

    Meldola, Italy

    Recruiting
  • Research Site

    Milan, Italy

    Recruiting
  • Research Site

    Monza, Italy

    Recruiting
  • Research Site

    Padova, Italy

    Recruiting
  • Research Site

    Perugia, Italy

    Recruiting
  • Research Site

    Pisa, Italy

    Recruiting
  • Research Site

    Roma, Italy

    Recruiting
  • Research Site

    Rozzano, Italy

    Recruiting
Portugal
  • Research Site

    Lisbon, Portugal

    Recruiting
  • Research Site

    Lisbon, Portugal

    Recruiting
  • Research Site

    Lisbon, Portugal

    Recruiting
  • Research Site

    Lisbon, Portugal

    Recruiting
57 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Apr 2022
Primary completion
28 May 2030
Completion
28 May 2030
Last update posted
23 Jun 2026
Registered enrollment
630
Registry id
NCT05061550

Cross-registrations

EU-CTR / CTIS (EudraCT)2021-003369-37EU-CTR / CTIS (EudraCT)2023-508852-21-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.